BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34143366)

  • 1. microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C.
    Wang Y; Ye H; Yang Y; Li J; Cen A; Zhao L
    J Endocrinol Invest; 2022 Jan; 45(1):17-28. PubMed ID: 34143366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2492-2505. PubMed ID: 31565805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C.
    Liu J; Zhu M; Tang Q
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2867-2877. PubMed ID: 34218325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
    Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-181a promotes cell proliferation and migration through targeting KLF15 in papillary thyroid cancer.
    Sun CX; Liu BJ; Su Y; Shi GW; Wang Y; Chi JF
    Clin Transl Oncol; 2022 Jan; 24(1):66-75. PubMed ID: 34312797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
    Wang Y; Xu J; Zhu X; Kuang H
    Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
    Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
    Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1.
    Tan J; Li C; Ren L; Zhu X; Hua F; Fu Y
    Mol Cell Probes; 2022 Dec; 66():101863. PubMed ID: 36252912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Zheng H; Fu Q; Ma K; Shi S; Fu Y
    Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.
    Sun Y; Shi T; Ma Y; Qin H; Li K
    Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
    Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
    Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
    Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
    Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression.
    Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
    J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN.
    Guo K; Wang J; Shu L; Zhou G
    Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-181a-5p Regulates NIS Expression in Papillary Thyroid Carcinoma.
    Gierlikowski W; Broniarek K; Cheda Ł; Rogulski Z; Kotlarek-Łysakowska M
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-200c-3p Negatively Regulates ATP2A2 and Promotes the Progression of Papillary Thyroid Carcinoma.
    Feng YL; Ke T; Wang GL; Qi HY; Xiao Y
    Biochem Genet; 2022 Oct; 60(5):1676-1694. PubMed ID: 35079913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
    Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
    J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.